Integra LifeSciences has identified issues with certain wound and burn products that have resulted in serious injuries, the Food and Drug Administration said.
Monday, Integra LifeSciences Holdings Corporation (NASDAQ:IART) reported first-quarter revenues of $368.9 million, down 3.1% Y/Y on a reported basis and 2.5% on an organic basis, beating the consensus ...
PRINCETON, N.J., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Company (NASDAQ: IART), a leading global medical technology company, today issued its latest Environmental, Social and ...
On Monday, Integra LifeSciences Holdings Corporation (NASDAQ:IART) reported third-quarter adjusted EPS of $0.41, down from $0.76 a year ago, beating the consensus of $0.39. The company reported sales ...
PRINCETON, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (IART) (Nasdaq:IART) today announced the appointment of Dr. Raymond Turner as its new corporate vice ...
Jan De Witte to retire as CEO by the end of 2024Stuart Essig appointed executive chairman of the Board “We are grateful to Jan for his leadership and commitment to Integra and the role he has played ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback